JPWO2020081987A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020081987A5 JPWO2020081987A5 JP2021521143A JP2021521143A JPWO2020081987A5 JP WO2020081987 A5 JPWO2020081987 A5 JP WO2020081987A5 JP 2021521143 A JP2021521143 A JP 2021521143A JP 2021521143 A JP2021521143 A JP 2021521143A JP WO2020081987 A5 JPWO2020081987 A5 JP WO2020081987A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- trm
- expressing
- expression
- hypoxia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025018950A JP2025084776A (ja) | 2018-10-18 | 2025-02-07 | 組織常在メモリー様ｔ細胞を生成するための方法及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862747523P | 2018-10-18 | 2018-10-18 | |
| US62/747,523 | 2018-10-18 | ||
| US201962846270P | 2019-05-10 | 2019-05-10 | |
| US62/846,270 | 2019-05-10 | ||
| PCT/US2019/057016 WO2020081987A1 (en) | 2018-10-18 | 2019-10-18 | Methods for production of tissue resident memory-like t cells and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018950A Division JP2025084776A (ja) | 2018-10-18 | 2025-02-07 | 組織常在メモリー様ｔ細胞を生成するための方法及びその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022505194A JP2022505194A (ja) | 2022-01-14 |
| JPWO2020081987A5 true JPWO2020081987A5 (https=) | 2022-10-21 |
| JP2022505194A5 JP2022505194A5 (https=) | 2022-10-21 |
| JP7698577B2 JP7698577B2 (ja) | 2025-06-25 |
Family
ID=70284129
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521143A Active JP7698577B2 (ja) | 2018-10-18 | 2019-10-18 | 組織常在メモリー様ｔ細胞を生成するための方法及びその使用 |
| JP2025018950A Withdrawn JP2025084776A (ja) | 2018-10-18 | 2025-02-07 | 組織常在メモリー様ｔ細胞を生成するための方法及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018950A Withdrawn JP2025084776A (ja) | 2018-10-18 | 2025-02-07 | 組織常在メモリー様ｔ細胞を生成するための方法及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12319740B2 (https=) |
| EP (1) | EP3866814A4 (https=) |
| JP (2) | JP7698577B2 (https=) |
| KR (1) | KR20210078518A (https=) |
| CN (1) | CN113056276A (https=) |
| CA (1) | CA3115487A1 (https=) |
| WO (1) | WO2020081987A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12365871B2 (en) | 2020-04-28 | 2025-07-22 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| GB202007321D0 (en) * | 2020-05-18 | 2020-07-01 | Inst De Medicina Molecular Joaeo Lobo Antunes | T cells |
| CN111944749A (zh) * | 2020-08-14 | 2020-11-17 | 福建医科大学附属协和医院 | 一种用于治疗心肌梗死的人脂肪间充质干细胞外泌体的制备方法 |
| CN112516141A (zh) * | 2020-12-07 | 2021-03-19 | 浙江大学 | Cd47表达抑制剂及其与免疫治疗药物联合使用 |
| US20240368545A1 (en) * | 2021-05-07 | 2024-11-07 | Yasuhito TOKUMOTO | Manufacturing method of memory t cells |
| US20250281539A1 (en) * | 2022-05-10 | 2025-09-11 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Methods of culturing tumor infiltrating lymphocytes |
| CN115975921B (zh) * | 2022-12-09 | 2025-12-19 | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 一种体外诱导组织驻留性记忆cd8+t细胞的方法 |
| WO2024253594A1 (en) * | 2023-06-07 | 2024-12-12 | Agency For Science, Technology And Research | Small molecule based method of modifying t cells |
| WO2025076124A1 (en) * | 2023-10-02 | 2025-04-10 | Immunitybio, Inc. | Methods of generating, stimulating, or increasing proliferation of different subsets of cd8+ t cells |
| WO2025096644A1 (en) * | 2023-10-31 | 2025-05-08 | Immunitybio, Inc. | Multi-chain chimeric polypeptides and use thereof in the treatment of advanced solid tumors |
| WO2025129119A1 (en) * | 2023-12-15 | 2025-06-19 | La Jolla Institute For Immunology | Gpr25 agonization for cancer therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962318A (en) * | 1996-11-15 | 1999-10-05 | St. Jude Children's Research Hospital | Cytotoxic T lymphocyte-mediated immunotherapy |
| US20080131415A1 (en) | 2006-11-30 | 2008-06-05 | Riddell Stanley R | Adoptive transfer of cd8 + t cell clones derived from central memory cells |
| US10316289B2 (en) * | 2012-09-06 | 2019-06-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of producing T memory stem cell populations |
| CN106146395B (zh) | 2015-03-27 | 2019-01-01 | 沈阳三生制药有限责任公司 | 3-羟基吡啶化合物、其制备方法及其制药用途 |
| WO2017015024A1 (en) | 2015-07-20 | 2017-01-26 | Mayo Foundation For Medical Education And Research | Methods and materials for producing t cells |
| WO2017079113A1 (en) | 2015-11-02 | 2017-05-11 | The United States Of America, As Represented By The Secretary, Department Of Healh And Human Services | Methods of producing t cell populations using prolyl hydroxylase domain-containing protein inhibitors |
| US20200078401A1 (en) | 2016-12-07 | 2020-03-12 | La Jolla Institute For Allergy And Immunology | Compositions for cancer treatment and methods and uses for cancer treatment and prognosis |
| US20240197782A1 (en) * | 2021-04-20 | 2024-06-20 | Board Of Regents, The University Of Texas System | Methods and compositions for genetic modification and therapeutic use of immune cells |
-
2019
- 2019-10-18 KR KR1020217014543A patent/KR20210078518A/ko not_active Ceased
- 2019-10-18 CA CA3115487A patent/CA3115487A1/en active Pending
- 2019-10-18 JP JP2021521143A patent/JP7698577B2/ja active Active
- 2019-10-18 EP EP19872505.3A patent/EP3866814A4/en active Pending
- 2019-10-18 CN CN201980076103.7A patent/CN113056276A/zh active Pending
- 2019-10-18 WO PCT/US2019/057016 patent/WO2020081987A1/en not_active Ceased
- 2019-10-18 US US17/286,086 patent/US12319740B2/en active Active
-
2025
- 2025-02-07 JP JP2025018950A patent/JP2025084776A/ja not_active Withdrawn
- 2025-04-11 US US19/176,646 patent/US20250320306A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Symowski et al. | Th2 cell‐derived IL‐4/IL‐13 promote ILC2 accumulation in the lung by ILC2‐intrinsic STAT6 signaling in mice | |
| Clemente-Casares et al. | Expanding antigen-specific regulatory networks to treat autoimmunity | |
| Selck et al. | Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation | |
| Mindt et al. | Group 2 innate lymphoid cells in pulmonary immunity and tissue homeostasis | |
| Murai et al. | Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis | |
| JPWO2020081987A5 (https=) | ||
| White et al. | Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses | |
| Doherty | At the bench: understanding group 2 innate lymphoid cells in disease | |
| Possot et al. | Notch signaling is necessary for adult, but not fetal, development of RORγt+ innate lymphoid cells | |
| Baeten et al. | Improving the efficacy of regulatory T cell therapy | |
| Kasahara et al. | Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model | |
| Yoshimatsu et al. | Aryl hydrocarbon receptor signals in epithelial cells govern the recruitment and location of Helios+ Tregs in the gut | |
| Geem et al. | Harnessing regulatory T cells for the treatment of inflammatory bowel disease | |
| JP2019518460A (ja) | 操作されたＴｒｅｇ細胞 | |
| Sanders et al. | Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation | |
| Tanaka et al. | IL-22 is required for the induction of bronchus-associated lymphoid tissue in tolerant lung allografts | |
| Das et al. | Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut | |
| Bacchetta et al. | Thymic origins of autoimmunity—lessons from inborn errors of immunity | |
| Takatsuki et al. | Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance | |
| Hashimoto et al. | Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes | |
| Haque et al. | FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development | |
| Reid et al. | Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responses | |
| JPWO2019191501A5 (https=) | ||
| Najar et al. | Microbiota-induced plastic T cells enhance immune control of antigen-sharing tumors | |
| Raveney et al. | Neuropilin‐1 (NRP1) expression distinguishes self‐reactive helper T cells in systemic autoimmune disease |